ATE538666T1 - Nahrungsergänzung zur verhinderung von abmagerungen - Google Patents

Nahrungsergänzung zur verhinderung von abmagerungen

Info

Publication number
ATE538666T1
ATE538666T1 AT08785226T AT08785226T ATE538666T1 AT E538666 T1 ATE538666 T1 AT E538666T1 AT 08785226 T AT08785226 T AT 08785226T AT 08785226 T AT08785226 T AT 08785226T AT E538666 T1 ATE538666 T1 AT E538666T1
Authority
AT
Austria
Prior art keywords
weight loss
dietary supplement
prevent weight
composition
cachexia
Prior art date
Application number
AT08785226T
Other languages
English (en)
Inventor
Christina Schneid
Original Assignee
Fresenius Kabi De Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39326729&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE538666(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Fresenius Kabi De Gmbh filed Critical Fresenius Kabi De Gmbh
Application granted granted Critical
Publication of ATE538666T1 publication Critical patent/ATE538666T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Botany (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Control Of Eletrric Generators (AREA)
  • Oscillators With Electromechanical Resonators (AREA)
  • Medicines Containing Plant Substances (AREA)
AT08785226T 2007-07-31 2008-07-30 Nahrungsergänzung zur verhinderung von abmagerungen ATE538666T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07015027A EP2025248A1 (de) 2007-07-31 2007-07-31 Zubehör zur Verhinderung von Abmagerungen
PCT/EP2008/006281 WO2009015879A1 (en) 2007-07-31 2008-07-30 Cachexia prevention supplement

Publications (1)

Publication Number Publication Date
ATE538666T1 true ATE538666T1 (de) 2012-01-15

Family

ID=39326729

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08785226T ATE538666T1 (de) 2007-07-31 2008-07-30 Nahrungsergänzung zur verhinderung von abmagerungen

Country Status (7)

Country Link
US (1) US20100189816A1 (de)
EP (2) EP2025248A1 (de)
JP (1) JP2010534697A (de)
CN (1) CN101801219A (de)
AT (1) ATE538666T1 (de)
ES (1) ES2380164T3 (de)
WO (1) WO2009015879A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL1036746C2 (nl) * 2009-03-20 2010-09-21 Glnp Holding B.V. Kit van onderdelen bevattende l-glutamine en egcg.
US20100255119A1 (en) * 2009-04-04 2010-10-07 Christina Schneid Mucositis Prevention Supplement and Treatment
WO2010137944A1 (en) * 2009-05-27 2010-12-02 N.V. Nutricia Treatment of hypercalcaemia
IT1395408B1 (it) * 2009-08-31 2012-09-14 Cangiano Formulazione farmaceutica a base di aminoacidi a catena ramificata per la cura della sindrome anoressia nausea e vomito (sanv) da chemioterapici
JP5576097B2 (ja) * 2009-11-17 2014-08-20 大塚製薬株式会社 気道抵抗改善剤
CN103458891A (zh) * 2011-04-13 2013-12-18 味之素株式会社 营养组合物
KR101393496B1 (ko) 2014-02-25 2014-05-13 유원석 봉합사 삽입키트
US20200085774A1 (en) * 2016-12-23 2020-03-19 Basf As Omega-3 Fatty Acid Composition for Preventing and/or Treating Cachexia
WO2019109050A1 (en) 2017-11-30 2019-06-06 University Of South Florida Prevention and treatment of muscle wasting with ketone supplementation
KR102066388B1 (ko) * 2018-03-09 2020-01-15 코스맥스엔에스 주식회사 캐모마일 추출물을 포함하는 근기능 및 운동능 강화 기능성 식품 조성물 및 그 제조방법
KR102375935B1 (ko) * 2019-12-27 2022-03-17 경희대학교 산학협력단 피페린을 함유하는 암성 악액질 예방, 개선 또는 치료용 조성물
KR102935226B1 (ko) 2023-06-09 2026-03-09 주식회사 메타파인즈 악액질 및 근손실의 예방 또는 치료용 조성물

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8906369D0 (en) * 1989-03-20 1989-05-04 Tisdale Michael J Eicosapentaenoic acid
US6077828A (en) * 1996-04-25 2000-06-20 Abbott Laboratories Method for the prevention and treatment of cachexia and anorexia
CA2339473A1 (en) * 1998-08-04 2000-02-17 John V. Kosbab Nutrient and therapeutic compositions for the treatment of cancer
US6649195B1 (en) * 2002-07-11 2003-11-18 Vitacost.Com, Inc. Eyesight enhanced maintenance composition
US20040087490A1 (en) * 2002-09-20 2004-05-06 Troup John P. Nutritional compositions
GB0308104D0 (en) * 2003-04-08 2003-05-14 Novartis Nutrition Ag Organic compounds
CN103211806B (zh) * 2003-05-27 2015-09-09 帝斯曼知识产权资产管理有限公司 新颖的营养药物性组合物及其用途
US20050032757A1 (en) * 2003-08-06 2005-02-10 Cho Suk H. Nutritional supplements
WO2005110124A1 (en) * 2004-04-15 2005-11-24 Abbott Laboratories Composition and methods for nutritional management of patients with hepatic disease
DE202005012984U1 (de) * 2005-08-17 2005-11-24 W & B Pharmamarken Gmbh Arzneimittel- und Nahrungsergänzungsmittelkombinationen zur Behandlung von Augenerkrankungen
US7507425B2 (en) * 2005-09-27 2009-03-24 The Quigley Corporation Method for the treatment of cachexia
EP2031983A2 (de) * 2006-06-23 2009-03-11 The Procter and Gamble Company Konzentrierte omega-3-fettsäuren und diese enthaltende mischungen
DE202006014588U1 (de) * 2006-09-20 2006-12-14 Orthomol Pharmazeutische Vertriebs Gmbh Carotinoide-enthaltendes Produkt
DE202007000949U1 (de) * 2007-01-23 2007-04-12 Vogel Lukas Nahrungsergänzungsmittel, bilanzierte Diät oder Arzneimittel für besonders medizinische Zwecke

Also Published As

Publication number Publication date
JP2010534697A (ja) 2010-11-11
US20100189816A1 (en) 2010-07-29
EP2170103B1 (de) 2011-12-28
CN101801219A (zh) 2010-08-11
HK1143047A1 (en) 2010-12-24
WO2009015879A1 (en) 2009-02-05
EP2025248A1 (de) 2009-02-18
ES2380164T3 (es) 2012-05-09
EP2170103A1 (de) 2010-04-07

Similar Documents

Publication Publication Date Title
ATE538666T1 (de) Nahrungsergänzung zur verhinderung von abmagerungen
ECSP045208A (es) Aza-arilpiperazinas
BR0214343A (pt) Inibidores de 11 - beta - hidroxi esteróide desidrogenase tipo 1
MX2007008021A (es) Composiciones que incluyen hierro.
IL196543A (en) Pyridazinone derivatives, pharmaceutical preparations containing them for use in the treatment of disorders
WO2008154083A3 (en) Compounds, compositions and methods for the treatment of synucleinopathies
MXPA05009933A (es) Composiciones que comprenden acidos grasos y aminoacidos.
PT2170090E (pt) Óleos enriquecidos com hidroxitirosol e suas utilizações
ZA200802454B (en) Use of thienopyridone derivatives as AMPK activators and pharmaceutical compositions containing them
MXPA04004837A (es) Inhibidores de 11-??-hidroxiesteroide deshidrogenasa de tipo 1.
MY148723A (en) Use of pinolenic acid for the treatment of obesity
ATE406882T1 (de) Zusammensetzungen zur normalisierung des zirkadianen rythmus
EA200802223A1 (ru) 1,5-дифенилпиразолы ii в качестве ингибиторов hsp90
WO2010067078A3 (en) 3,6-disubstituted xanthylium salts as medicaments
TNSN08321A1 (en) Dimers of artemisinin derivatives, preparation thereof and therapeutic use thereof
WO2008094825A3 (en) Compositions and methods for maintaining, strengthening, improving or promoting eye health
UY27204A1 (es) Derivados de pieracina
ATE554753T1 (de) 2,2'-dithio-bis(ethansulfonat) für den einsatz zur hemmung paclitaxel-induzierter abnormer thermoesthesia
DE602005016803D1 (de) Zusammensetzungen mit strontium und vitamin d und ihre verwendungen
WO2011019735A3 (en) Nutritional supplements
IL229594A (en) Derived Lactone Derivatives, Pharmaceutical Compositions Containing Them and Their Uses in the Preparation of Medical Preparations for Cancer Treatment
TW200612903A (en) Use of trisubstituted benzopyranones
WO2005110413A3 (en) Medicaments containing n-sulfamoyl-n'-arylpiperazines for the prophylaxis or treatment of obesity and related conditions
EP2392337A3 (de) Verwendung von 24-norUDCA
DE50310932D1 (de) Sporopollenin enthaltende lösliche zusammensetzung und verwendung